date:Aug 12, 2013
ments. FDA will reinspect to determine whether corrective and effective actions have been implemented and compliance has been achieved to the agency's satisfaction.
Highlights for FY 2014
No invoices will be issued for fees related to recalls or reinspections until FDA publishes guidance that details how small businesses may request a reduction in fees. That means all companies, regardless of size, should not be billed until the new guidance is issued.
In last years notice, FDA said it would